Diff Profiles › MTBLS354_0002_00000001

CAP_Cases_vs_Non_CAP_Controls

CAP_Cases vs Non-CAP_Controls

p-value ≤ 0.05 7 significant 2025-09-26 00:00:00 Study: MTBLS354
7 Total Features
7 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS354_0002_00000001
Linked study
MTBLS354 — Lipid metabolites as potential diagnostic and prognostic biomarkers for acute community acquired pneumonia
Comparison
CAP_Cases vs Non-CAP_Controls
Group A
Patients diagnosed with community-acquired pneumonia.. This group is crucial for identifying biomarkers specific to CAP.
Group B
Patients without community-acquired pneumonia.. This group serves as the baseline for identifying CAP-specific biomarkers.
Total features tested
7
Significant features
7
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
HLIJNIKSBCIDGO-QKLMXXKVSA-N N-(hexadecanoyl)-1-b-lactosyl-sphing-4-enine up 2.318 3.1e-19
MGOOTGNGBOPVIV-VVNLPLDBSA-N Gb3(d18:1/16:0) up 2.181 2.73e-18
QHZIGNLCLJPLCU-QPPIDDCLSA-N {[(2S,3R)-2-hexadecanamido-3-hydroxyoctadecyl]oxy}[2-(trimethylazaniumyl)ethoxy]phosphinic acid up 2.786 9.53e-14
XOMRRQXKHMYMOC-OAQYLSRUSA-N Hexadecenoyl carnitine up 2.984 1.04e-12
RWKUXQNLWDTSLO-GWQJGLRPSA-N <em>N</em>-hexadecanoylsphingomyelin up 1.541 1.64e-25
BLRBAJXLYBVISP-FQSSPVBCSA-N — up 2.057 1.07e-13
YAMUFBLWGFFICM-PTGWMXDISA-N 1-Oleoylglycerophosphocholine up 2.403 1.21e-09